An in vitro model for evaluating peripheral regulation of growth in fish: effects of 17β-estradiol and testosterone on the expression of growth hormone receptors, insulin-like growth factors, and insulin-like growth factor type 1 receptors in rainbow trout (Oncorhynchus mykiss)

Gen Comp Endocrinol. 2011 Sep 1;173(2):270-80. doi: 10.1016/j.ygcen.2011.06.009. Epub 2011 Jun 14.

Abstract

A central component of growth coordination in vertebrates is the growth hormone (GH)-insulin-like growth factor-1 (IGF-1) system. To date, most studies on the control of vertebrate growth have focused on regulation of pituitary GH production and release. In this study, we used liver, muscle, and gill tissue from sexually immature rainbow trout incubated in vitro to evaluate the extrapituitary effects of 17β-estradiol (E2) and testosterone (T) on mRNA and functional expression of growth hormone receptors (GHR), insulin-like growth factors 1 and 2 (IGF-1, IGF-2), and type 1 IGF receptors (IGFR1). E2 significantly decreased steady-state levels of GHR1, GHR2, and IGF-1 mRNAs in liver as well as of GHR1 and GHR2 mRNAs in muscle and of IGF-1 and IGF-2 mRNAs in gill in a time- and concentration-dependent manner. E2 had no effect on levels of IGFR1 mRNAs in muscle or on GHR and IGFR1 mRNAs in gill. Functional expression of GHRs as assessed by (125)I-GH binding capacity was reduced by E2 in liver and muscle; however, E2 did not affect (125)I-IGF-1 binding capacity in muscle or (125)I-GH and (125)I-IGF-1 binding capacity in gill. By contrast, T increased steady-state levels of GHR1, GHR2, IGF-1, and IGF-2 mRNAs in liver, of GHR1, GHR2, IGFR1A, and IGFR1B in muscle, and of GHR1, GHR2, IGF-1, IGF-2, IGFR1A, and IGFR1B mRNAs in gill in a time- and concentration-dependent manner. Binding capacity of (125)I-GH in liver and of (125)I-GH and (125)I-IGF-1 in both muscle and gill also was increased by T. These data indicate that E2 and T directly affect peripheral aspects of the GH-IGF system, and suggest, at least in immature rainbow trout, that E2 reduces hepatic sensitivity to GH as well as reduces peripheral production of IGFs and that T increases peripheral sensitivity to GH and IGF as well as increases peripheral production of IGFs.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Estradiol / pharmacology*
  • Gene Expression / drug effects
  • Gene Expression / genetics
  • Oncorhynchus mykiss / genetics
  • Oncorhynchus mykiss / metabolism*
  • Receptor, IGF Type 1 / genetics
  • Receptor, IGF Type 1 / metabolism*
  • Receptors, Somatotropin / genetics
  • Receptors, Somatotropin / metabolism*
  • Somatomedins / genetics
  • Somatomedins / metabolism*
  • Testosterone / pharmacology*

Substances

  • Receptors, Somatotropin
  • Somatomedins
  • Testosterone
  • Estradiol
  • Receptor, IGF Type 1